company background image
A053030 logo

BINEX KOSDAQ:A053030 Stock Report

Last Price

₩16.26k

Market Cap

₩517.8b

7D

-12.1%

1Y

102.0%

Updated

24 Nov, 2024

Data

Company Financials +

BINEX Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BINEX
Historical stock prices
Current Share Price₩16,260.00
52 Week High₩27,300.00
52 Week Low₩7,710.00
Beta0.51
11 Month Change-21.07%
3 Month Change-31.68%
1 Year Change101.99%
33 Year Change4.57%
5 Year Change112.55%
Change since IPO755.79%

Recent News & Updates

Recent updates

BINEX Co., Ltd. (KOSDAQ:053030) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Nov 18
BINEX Co., Ltd. (KOSDAQ:053030) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Oct 23
Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For BINEX Co., Ltd. (KOSDAQ:053030) After Shares Rise 25%

Sep 01
Revenues Not Telling The Story For BINEX Co., Ltd. (KOSDAQ:053030) After Shares Rise 25%

Subdued Growth No Barrier To BINEX Co., Ltd. (KOSDAQ:053030) With Shares Advancing 32%

Jul 01
Subdued Growth No Barrier To BINEX Co., Ltd. (KOSDAQ:053030) With Shares Advancing 32%

BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk

Apr 17
BINEX Co., Ltd.'s (KOSDAQ:053030) 30% Share Price Plunge Could Signal Some Risk

We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings

Mar 22
We Think That There Are More Issues For BINEX (KOSDAQ:053030) Than Just Sluggish Earnings

BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up

Feb 26
BINEX Co., Ltd.'s (KOSDAQ:053030) Shares Climb 37% But Its Business Is Yet to Catch Up

Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

Mar 18
Does BINEX (KOSDAQ:053030) Have A Healthy Balance Sheet?

If You Had Bought BINEX (KOSDAQ:053030) Stock A Year Ago, You Could Pocket A 253% Gain Today

Jan 28
If You Had Bought BINEX (KOSDAQ:053030) Stock A Year Ago, You Could Pocket A 253% Gain Today

Are BINEX Co., Ltd.'s (KOSDAQ:053030) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Dec 24
Are BINEX Co., Ltd.'s (KOSDAQ:053030) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Shareholder Returns

A053030KR PharmaceuticalsKR Market
7D-12.1%-3.1%2.9%
1Y102.0%4.8%-2.8%

Return vs Industry: A053030 exceeded the KR Pharmaceuticals industry which returned 4.8% over the past year.

Return vs Market: A053030 exceeded the KR Market which returned -2.8% over the past year.

Price Volatility

Is A053030's price volatile compared to industry and market?
A053030 volatility
A053030 Average Weekly Movement11.5%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A053030's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A053030's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1957552Hyuk-Jong Leewww.bi-nex.co.kr

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production.

BINEX Co., Ltd. Fundamentals Summary

How do BINEX's earnings and revenue compare to its market cap?
A053030 fundamental statistics
Market cap₩517.84b
Earnings (TTM)-₩18.86b
Revenue (TTM)₩128.30b

4.0x

P/S Ratio

-27.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A053030 income statement (TTM)
Revenue₩128.30b
Cost of Revenue₩101.86b
Gross Profit₩26.44b
Other Expenses₩45.30b
Earnings-₩18.86b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-592.18
Gross Margin20.61%
Net Profit Margin-14.70%
Debt/Equity Ratio35.2%

How did A053030 perform over the long term?

See historical performance and comparison